Estradiol Transdermal Spray in the Treatment of Vasomotor Symptoms

• Status: Completed
• Trial end date: 2006-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

Estradiol treatment is effective at reducing vasomotor symptoms (eg hot flushes) in postmenopausal women. This study will evaluate the safety and efficacy of Evamist.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lumara Health, Inc.
• Treatments: Estradiol; Estradiol 17 beta-cypionate; Estradiol 3-benzoate; Estradiol valerate; Polyestradiol phosphate

Criteria

Inclusion Criteria:

• Post menopausal women,

• Ages 35 or older,

• Frequent moderate to severe hot flushes,

• Qualifying general medical health

Exclusion Criteria:

• Disqualifying gynecological disorders,

• Disqualifying dermatological disorders,

• Disqualifying concurrent conditions